Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hoekman

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosisK Hoekman, S E Papapoulos, A C Peters, et al.
Angiogenesis|May 29, 2004
VEGF and endostatin levels in wound fluid and plasma after breast surgeryF P K Wu, K Hoekman, S Meijer, et al.
European Journal of Cancer Care|June 16, 2004
Clarifying the term 'palliative' in clinical oncologyT van Kleffens, B Van Baarsen, K Hoekman, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 25, 2000
[Coagulation disorders in cancer patients: possible opportunity for therapy]J B Bom, H M Verheul, K Hoekman, et al.
Journal of Neuro-Oncology|June 27, 2003
Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancerC C P Verstappen, T J Postma, K Hoekman, et al.
Cytokine|June 9, 2001
Granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases left ventricular function. An echocardiographic study in cancer patientsS Knoops, A B Groeneveld, O Kamp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonateS E Papapoulos, K Hoekman, C W Löwik, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Well-differentiated papillary mesothelioma of the peritoneum: a separate entityK Hoekman, G Tognon, E K Risse, et al.
The Oncologist|May 10, 2000
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formationH M Verheul, K Hoekman, A S Jorna, et al.
Prostaglandins|June 1, 1992
Secretory diarrhea in villous adenoma of rectum: effect of treatment with somatostatin and indomethacinA H Smelt, A E Meinders, K Hoekman, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosisK Hoekman, S E Papapoulos, A C Peters, et al.
Angiogenesis|May 29, 2004
VEGF and endostatin levels in wound fluid and plasma after breast surgeryF P K Wu, K Hoekman, S Meijer, et al.
European Journal of Cancer Care|June 16, 2004
Clarifying the term 'palliative' in clinical oncologyT van Kleffens, B Van Baarsen, K Hoekman, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 25, 2000
[Coagulation disorders in cancer patients: possible opportunity for therapy]J B Bom, H M Verheul, K Hoekman, et al.
Journal of Neuro-Oncology|June 27, 2003
Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancerC C P Verstappen, T J Postma, K Hoekman, et al.
Cytokine|June 9, 2001
Granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases left ventricular function. An echocardiographic study in cancer patientsS Knoops, A B Groeneveld, O Kamp, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonateS E Papapoulos, K Hoekman, C W Löwik, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Well-differentiated papillary mesothelioma of the peritoneum: a separate entityK Hoekman, G Tognon, E K Risse, et al.
The Oncologist|May 10, 2000
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formationH M Verheul, K Hoekman, A S Jorna, et al.
Prostaglandins|June 1, 1992
Secretory diarrhea in villous adenoma of rectum: effect of treatment with somatostatin and indomethacinA H Smelt, A E Meinders, K Hoekman, et al.
Pageof 7